76
Views
5
CrossRef citations to date
0
Altmetric
Review

Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy

Pages 169-179 | Published online: 03 Mar 2005

Bibliography

  • SPIRITO F, MENEGUZZI G, DANOS 0, MEZZINA M: Cutaneous gene transfer and therapy: the present and the future. j Gene Med. (2001) 3(1):21–31.
  • MAGNALDO T, SARASIN A: Genetic reversion of inherited skin disorders. Mutat Res. (2002) 509(1-2):211–220.
  • FRIEDBERG E: How nucleotide excision repair protects again cancer. Nat. Rev Cancer (2001) 1(1):22–33.
  • KRAEMER K, LEE M, SCOTTO J: Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch. Dermatol. (1987) 123(2):241–250.
  • ••The largest clinical study of a cohort ofXP patients.
  • SPATZ A, GIGLIA-MARI G,BENHAMOU S, SARASIN A: Association between DNA repair-deficiency and high level of p53 mutations in melanoma of xeroderma pigmentosum. Cancer Res. (2001) 61(6):2480–2486.
  • •The first molecular study of malignant melanoma from XP patients.
  • SPATZ A, BERNERD F, SARASIN A, MAGNALDO T: Spontaneous and photo-induced proliferation and differentiation alterations in DNA repair deficient/cancer prone xeroderma pigmentosum skin in vivo. Am. Pathol (2004) (Submitted).
  • DE BOER J, HOEIJMAKERS JH: Nucleotide excision repair and human syndromes. Carcinogenesis (2000) 21(3):453–460.
  • STARY A, SARASIN A: The genetics of the hereditary xeroderma pigmentosum syndrome. Biochimie (2002) 84(1):49–60.
  • DE LAAT WL, JASPERS NG,HOEIJMAKERS JH: Molecular mechanism of nucleotide excision repair. Genes Dev. (1999) 13(7):768–785.
  • BROUGHTON BC, CORDONNIER A, KLEIJER WJ et al.: Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc. NatL Acad. Sci. USA (2002) 99(2):815–820.
  • JOHNSON RE, KONDRATICK CM, PRAKASH S, PRAKASH L: hRAD30 mutations in the variant form of xeroderma pigmentosum [see comments]. Science (1999) 285(5425):263–265.
  • MASUTANI C, KUSUMOTO R, YAMADA A et al.: The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta [see comments]. Nature (1999) 399(6737):700–704.
  • WATSON J, CRICK F: A structure for desoxiribonucleic acid. Nature (1953) 171(4356):737–738.
  • KRAEMER KH: Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sri. USA (1997) 94(1):11–14.
  • DEPINHO RA: The age of cancer. Nature (2000) 408(6809):248–254.
  • ••A concise review connecting thetype of tumours with their age of occurrence in human.
  • GIGLIA-MARI G, SARASIN A: TP53 mutations in human skin cancer. Hum. Mutat (2003) 21(3):217–228.
  • ••A compilation of P53 gene mutations,showing for the first time that their nature and spectrum differ between basal and squarnous cell carcinomas.
  • SAGE E: Distribution and repair of photolesions in DNA: genetic consequences and the risk of sequence context. Photochem. Photobiol (1993) 57(1):163–174.
  • DOUKI T, CADET J: Individual determination of the yield of the UV-induced dimeric pyrimidine photoproducts in DNA suggests a high mutagenicity of CCphotolesions. Biochemistry (2001) 40(8):2495–2501.
  • •A very complete and precise study of mutation events as a function of DNA sequences, UV doses and their wavelengths.
  • KIM JK, PATEL D, CHOI BS: Contrasting structural impacts induced by cis-syn cyclobutane dimer and (6-4) adduct in DNA duplex decamers: implication in mutagenesis and repair activity. Photochem. Photobiol. (1995) 62(1):44–50.
  • SAGE E, LAMOLET B, BRULAY E, MOUSTACCHI E, CHATEAUNEUF A, DROBETSKY EA: Mutagenic specificity of solar UV light in nucleotide excision repair-deficient rodent cells. Proc. Natl. Acad. Sci. USA (1996) 93(1):176–178.
  • •One of the very first studies showing mutagenic effects of LTVA irradiation in an endogenous gene in mice.
  • ROBERT C, MUEL B, BENOIT A, DUBERTRET L, SARASIN A, STARY A: Cell survival and shuttle vector mutagenesis induced by ultraviolet A and ultraviolet B radiation in a human cell line. Invest. Dermatol (1996) 106(4):721–728.
  • ••The first study showing that the nature andspectrum of mutation in a shuttle vector is different depending on whether cells are exposed to either UVA or UVB radiation.
  • MEMIGLOSU A, SAMSON L: Base excision repair in yeast and mammals. Mutat Res. (2000) 451(1-2):39–51.
  • HSIEH P: Molecular mechanisms of DNA mismatch repair. Mutat Res. (2001) 486(2):71–87.
  • SARASIN A: The molecular pathways of ultraviolet-induced carcinogenesis. Mutat Res. (1999) 428(1-2):5–10.
  • KUSUMOTO R, MASUTANI C, SUGASAWA K, IWAI S, HANAOKA F: Diversity of the damage recognition step in the global genomic excision repair in vitro. Mutat Res. (2001) 485(3):219–227.
  • MELLON I, SPIVAC G, HANAWALT PC: Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell (1987) 51(2):241–249.
  • ••Demonstration that thetranscribed strands of active genes are repaired preferentially compared with the non-transcribed strands or inactive DNA regions.
  • SUGASAWA K, MASUTANI C, UCHIDA A et al.: HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair M vitro. Mol. Biol. (1996) 16(9):4852–4861.
  • SUGASAWA K, NG JM, MASUTANI C et al.: Xeroderma pigmentosum group C protein complex is the initiator of global genome nucleotide excision repair. Mol. Cell (1998) 2(2):223–232.
  • ••This paper provides the first evidenceof the role of XPC in the recognition step of NER.
  • WAKASUGI M, SHIMIZU M, MORIOKA H, LINN S,NIKAIDO 0, MATSUNAGA T: Damaged DNA-binding protein DDB stimulates the excision of cyclobutane pyrimidine dimers in vitro in concert with XPA and replication protein A.,/ Biol. Chem. (2001) 276(18):15434–15440.
  • CLINE SD, HANAWALT PC: Who's first in the cellular response to DNA damage? Nat. Rev Mol. Cell. Biol. (2003) 4(5):361–373.
  • REARDON J, SANCAR A: Recognition and repair of the cyclobutane thymine dimer, a major cause of skin cancer, by the human excision nuclease. Genes Dev. (2003) 17:1–13.
  • OTTO A, RIOU L, MARIONNET C, MORI T, SARASIN A, MAGNALDO T: Differential behaviors toward utraviolet A and B radiations of fibroblasts and keratinocytes from normal and DNA-repair deficient individuals. Cancer Res. (1999) 59(6):1212–1218.
  • LEHMANN AR: The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. (2001) 15(1):15–23.
  • DUBAELE S, PROIETTI DE SANTIS L, BIENSTOCK R et al.: Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy inXPD patients. Mol. Cell (2003) 11(6):1635–1646.
  • ••A systematic study of the effect of XPDgene mutations found in either trichotidystrophy or XP patients on transcription and DNA repair.
  • ZENG L, SARASIN A, MEZZINA M: Novel complementation assays for DNA repair-deficient cells. Transient and stable expression of DNA repair genes. Methods Mol. Biol. (1999) 113:87–100.
  • KRAEMER KH, DIGIOVANNA JJ, PECK GL: Chemoprevention of skin cancer in xeroderma pigmentosum. j Dermatol. (1992) 19(11):715–718.
  • CHAMBON P: A decade of molecular biology of retinoic acid receptors. FASEB (1996) 10(9):940–954.
  • FRIT P, KWON K, COIN F et al.: Transcriptional activators stimulate DNA repair. Mol. Cell (2002) 10(6): 1391–1401.
  • ••The first report showing that antiturnouraleffects of retinoids in part rely on the interaction between hormone-dependent nuclear receptors and the basal transcription machinery.
  • FISHER GJ, DATTA SC, TALWAR HS et al.: Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 379(6563)335–339.
  • ••The first report showing that anti-agingeffects of retinoids result in part from a competition for DNA regulatory sequences of AP1 proteins and nuclear receptors for retinoic acid.
  • FISHER GJ, WANG ZQ, DATTA SC, VARANI J, KANG S, VOORHEES JJ: Pathophysiology of premature skin aging induced by ultraviolet light. N Engl. J. Med. (1997) 337(20):1419–1428.
  • GALLICO GG, O& CONNOR NE, COMPTON CC, KEHINDE 0,GREEN H: Permanent coverage of large burn wounds with autologous cultured human epithelium. N Engl. J. Med. (1984) 311(7):448–451.
  • YAROSH D, KLEIN J, O'CONNOR A, HAWK J, RAFAL E, WOLF P: Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 357(9260):926–929.
  • •A convincing improvement of quality of life of XP patients after treatment with atopically applied formulation containing an active DNA repair protein.
  • WINKLER G, ARAUJO S, FIEDLER U et al.: TFIIH with inactive XPD helicase functions in transcription initiation but is defective in DNA repair. J. Biol. Chem. (2000) 275(6):4258–4266.
  • FRIEDBERG EC: Cancer predispositionassociated with defective DNA repair: studies with mutant mouse strains. Cancer-J. Sci. Am. (1999) 5(5):257–63.
  • BERNERD F, ASSELINEAU D,VIOUX C et al.: Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro. Proc. Nati Acad. Sci. USA (2001) 98(14):7817–7822.
  • •The first reconstruction of XP-C skin in vitro, revealing spontaneous defects of epidermal keratinocyte proliferation and differentiation.
  • ASSELINEAU D, BERNARD B, BAILLY C, DARMON M: Epidermal morphogenesis and induction of the 67 kD keratin polypeptide by culture of human keratinocytes at the liquid-air interface. Exp. Cell Res. (1985) 159(2):536–539.
  • FUCHS E, BYRNE C: The epidermis: rising to the surface. Carr: Opin. Genet. Dev. (1994) 4(5):725–736.
  • LUTZ J, HEEMANN U: Tumours after kindney transplantation. Can: Opin. Urol. (2003) 13(2):105–109.
  • CARREAU M, QUILLIET X, EVENO E et al.: Functional retroviral vector for gene therapy of xeroderma pigmentosumgroup D patients. Hum. Gene Ther. (1995) 6(10):1307–1315.
  • ZENG L, QUILLIET X,CHEVALLIER-LAGENTE 0, EVENO E, SARASIN A, MEZZINA M: Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C. Gene Ther. (1997) 4(10):1077–1084.
  • QUILLIET X,CHEVALLIER-LAGENTE 0, ZENG L et al.: Retroviral-mediated correction of DNA repair defect in xeroderma pigmentosum cells is associated with recovery of catalase activity. Mutat. Res. (1997) 385(3):235–242.
  • AHRENS C, GREWE M, BERNEBURG M et al.: Photocarcinogenesis and inhibition of intercellular adhesion molecule 1 expression in cells of DNA-repair-defective individuals. Proc. Nati Acad. Sci. USA (1997) 94(13):6837–6841.
  • DUMAZ N, DROUGARD C,QUILLIET X, MEZZINA M,SARASIN A, DAYA-GROSJEAN L: Recovery of the normal p53 response after UV treatment in DNA repair- deficient fibroblasts by retroviral-mediated correction with the XPD gene. Carcinogenesis (1998) 19(9):1701–1704.
  • DENG H, CHOATE KA, UN Q, KHAVARI PA: High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques (1998) 25(2):274–280.
  • CHAVANNE F, BROUGHTON BC, PIETRA D et al: Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels. Cancer Res. (2000) 60(7):1974–1982.
  • GOZUKARA EM, KHAN SG, METIN A et al.: A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: molecular genetic evidence for a common ancestor. J. Invest. Dermatol (2001) 117(2):197–204.
  • ARNAUDEAU-BE. GARD C, BRELLIER F,CHEVALLIER-LAGENTE 0 et al.: Genetic correction of DNA repair deficient/ cancer prone xeroderma pigmentosum group C keratinocytes. Hum. Gene Tiler: (2003) 14(10):983–996.
  • MATHOR MB, FERRARI G,DELLAMBRA E et al.: Clonal analysis of stably transduced human epidermal stem cells in culture. Proc. Nati Acad. Sci. USA (1996) 93(19):10371–10376.
  • ••Stable transduction of stemkeratinocytes and long-term expression of reporter genes is demonstrated for the first time by clonal analysis.
  • SHIMIZU Y, SHIGENORI I,HANAOKA, SUGASAWA K: Xeroderma pigmentosum group C protein interacts physically and functionally with thymine DNA glycosylase. EMBO (2003) 22(22):164–173.
  • ARAKI M, MASUTANI C,TAKEMURA M et al.: Centosome protein centrin2/calcatrin us part of the xeroderma pigmentosum group C complex that initiates global genome nucleotide excision repair. J. Biol Chem. (2001) 276(22):18665–18672.
  • HWANG B, FORD F, HANAWALT PC, CHU G: Expression of the p48xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA (1999) 96(2):424–428.
  • ADIMOOLAM S, FORD JM: p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene. Proc. Natl. Acad. Sci. USA (2002) 99(20):12985–12990.
  • •Expression of the XPCgene increases following UV irradiation through the activation of the P53 tumour suppressor protein, indicating that NER capacity may in part adapt to the physiological situation.
  • HARTMAN A-R, FORD JM: BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. (2002) 32(1):180–184.
  • IGOUCHEVA 0, YOON K: Targeted single-base correction by RNA-DNA oligonucleotides. Hum. Gene The]: (2000) 11(16):2307–2312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.